Palisade Bio (PALI) Cash from Investing Activities Growth (3y) (2013 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -34.83% |
| Sep 30, 2020 | 93.66% |
| Dec 31, 2018 | 91.24% |
| Mar 31, 2018 | 275.34% |
| Dec 31, 2017 | 82.49% |
| Sep 30, 2017 | 87.40% |
| Dec 31, 2016 | -279.16% |
| Jun 30, 2016 | 10.50% |
| Mar 31, 2016 | 329.74% |
| Dec 31, 2015 | -237.32% |
| Sep 30, 2015 | 538.80% |
| Jun 30, 2015 | 8.40% |
| Mar 31, 2015 | -50.61% |
| Dec 31, 2014 | -7.75% |
| Sep 30, 2014 | 10.45% |
| Jun 30, 2014 | 4.22% |
| Mar 31, 2014 | -443.75% |
| Dec 31, 2013 | 9.80% |
| Sep 30, 2013 | -33.02% |